St. Louis, Missouri
November 10, 2005
At an
investor meeting hosted by
Monsanto Company (NYSE: MON) today, executives announced
that the company expects continued strong ongoing earnings per
share (EPS) growth and free cash flow generation through 2007.
“Our seeds and traits business is
poised to drive our growth in the near- to mid-term, and our
technology pipeline and recent acquisitions will help us
strengthen our foundation as the leader in the agriculture
sector,” said Hugh Grant, Chairman, President and Chief
Executive Officer of Monsanto.
Company Announces Fiscal Year
2007 Guidance
As part of today’s presentation,
the company announced its growth projections for fiscal year
2007 and confirmed its fiscal year 2006 EPS guidance. EPS is
expected to be in the range of $2.82 to $3.00 on a reported and
an ongoing basis for fiscal year 2007, which reflects a 20
percent growth rate from the fiscal year 2006 EPS guidance. The
company confirmed that its fiscal year 2006 EPS is expected to
be in the range of $2.35 to $2.50, on a reported and an ongoing
basis, which reflects a growth rate of up to 20 percent from the
fiscal year 2005 EPS ongoing base of $2.08 per share. (For a
reconciliation of EPS, see note 1.)
Terry Crews, Executive Vice
President and Chief Financial Officer for Monsanto, also
indicated that the company expects free cash flow for fiscal
year 2007 to be in the range of $875 million to $950 million.
Guidance for free cash flow in fiscal year 2006 remains the same
in the range of $825 million to $900 million.(For a
reconciliation of free cash flow, see note 2.)
Pipeline Technologies Progress;
Seeds and Traits Set To Drive Additional Growth
As a part of the meeting,
executives described the company’s key growth objectives for its
seeds and traits platform. Grant began the investor meeting with
an overview of Monsanto’s current operations; highlighting the
company’s objectives over the next two to five years.
Following Grant’s presentation,
four other executives presented at the meeting – including:
-
Robb Fraley, Executive Vice President and Chief Technology
Officer;
- Carl
Casale, Executive Vice President and North America
Commercial Lead;
-
Brett Begemann, Executive Vice President and International
Commercial Lead; and,
- Terry
Crews, Executive Vice President and Chief Financial Officer.
Fraley’s presentation discussed
progress in the company’s research and development pipeline. He
highlighted Monsanto’s near-term products like its new soybean
technology, Roundup RReady2Yield soybeans, and Mavera™
High-Value Corn with lysine, the first processor-focused product
developed through Renessen, the company’s joint venture with
Cargill. Fraley also provided a 2005 field performance update on
the company’s yield platform – including nitrogen utilization
and drought-tolerance technology, which now has expanded to
cotton.
Following Fraley’s presentation,
Casale and Begemann provided an update on the company’s
strategic initiatives and product performance in key world
areas.
Casale’s presentation discussed
the growth potential of Monsanto’s corn and cotton traits
businesses in the mid-term. He noted that Monsanto’s seed
availability of Roundup Ready and YieldGard Rootworm technology
looks strong, and is expected to contribute to additional corn
trait growth in an expanding corn market.
Casale noted that Monsanto’s
Roundup Ready corn is likely to reach 60 million acres through
2010 – higher than the previous expectation of 50 million acres.
Monsanto’s YieldGard Corn Borer corn is likely to reach 50-60
million acres through 2010 – higher than the previous
expectation of 30-40 million acres. Monsanto’s YieldGard
Rootworm corn is likely to reach 25-30 million acres through
2010 – higher than the previous expectation of 15-20 million
acres.
Begemann’s presentation provided
an update on the Seminis vegetable and fruit seed business,
where breeding advancements are expected to deliver new hybrid
offerings in the near- to mid-term. Begemann concluded his
remarks with an update on the company’s expansion in key
agricultural markets around the world, including the approval of
Roundup Ready soybeans in Brazil. He also underscored the
company’s growth potential in corn- and cotton-growing markets.
Monsanto now expects business
growth through the adoption of second-generation cotton
technologies like Bollgard II and Roundup Ready Flex in
cotton-growing markets, like India and Australia. Additionally,
the company expects business growth in corn-growing markets,
like Brazil and Europe, with the adoption of Monsanto’s corn
trait technologies.
Monsanto
Company a leading global provider of technology-based solutions
and agricultural products that improve farm productivity and
food quality.
Note to editors: Bollgard II,
Roundup Ready, Roundup RReady2Yield and YieldGard are trademarks
owned by Monsanto Company and its wholly owned subsidiaries. The
Mavera trademark is owned by Renessen, LLC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
Ongoing EPS and Free Cash Flow:
The presentations of ongoing EPS and free cash flow are not
intended to replace net income (loss), cash flows, financial
position or comprehensive income (loss), and they are not
measures of financial performance as determined in accordance
with generally accepted accounting principles (GAAP) in the
United States. The following tables reconcile ongoing EPS and
free cash flow to the respective most directly comparable
financial measure calculated in accordance with GAAP.
1.
Reconciliation of EPS to Ongoing EPS: Ongoing EPS is
calculated excluding certain after-tax items which Monsanto does
not consider part of ongoing operations.
Total Monsanto Company and Subsidiaries:
|
Fiscal Year
2007
Target |
Fiscal Year 2006
Target |
Fiscal Year
2005 |
Fiscal Year
2004 |
|
|
|
|
|
Diluted Earnings (Loss) per Share |
$2.82 - $3.00 |
$2.35 - $2.50 |
$0.94 |
$0.99 |
In-Process R&D Write-Off Related to the
Seminis and Emergent
Acquisitions |
— |
— |
0.91 |
— |
Solutia-Related
Charge |
— |
— |
0.64 |
— |
Tax Benefit on Loss from European
Wheat and Barley Business |
— |
— |
(0.39) |
— |
Restructuring Charges – Net |
— |
— |
0.02 |
0.36 |
(Income) Loss on Discontinued Operations
and Related Restructuring
|
— |
— |
(0.04) |
— |
Impairment of Goodwill |
— |
— |
— |
0.24 |
Diluted Earnings (Loss) per Share from Ongoing
Business
|
$2.82 - $3.00 |
$2.35 - $2.50 |
$2.08 |
$1.59 |
2. Reconciliation of Free Cash Flow:
Free cash flow represents the total of cash flows from
operations and investing activities. With respect to the
projected free cash flow guidance provided under the caption
“Fiscal Year 2006 Target” and “Fiscal Year 2007 Target,”
Monsanto does not include any estimates or projections of Net
Cash Provided (Required) by Financing Activities because in
order to prepare any such estimate or projection, Monsanto would
need to rely on market factors and conditions that are outside
of its control.
Total Monsanto Company and Subsidiaries:
|
Fiscal Year
2007
Target |
Fiscal Year
2006
Target |
Fiscal Year
2005 |
Fiscal Year
2004 |
|
|
|
|
|
Net Cash Provided (Required) by
Operations |
$1,375 - $1,450 |
$1,175-$1,250 |
$1,737 |
$1,261 |
Net Cash Provided (Required) by Investing Activities
|
$(500) |
$(350) |
(1,667) |
(262) |
Free Cash Flow
|
$875 - $950 |
$825 - $900 |
$70 |
$999 |
Net Cash Provided (Required) by
Financing Activities
|
N/A |
N/A |
(582) |
(243) |
Net Increase (Decrease) in Cash and Cash Equivalents
|
N/A |
N/A |
(512) |
756 |
Cash and Cash Equivalents at Beginning of Period
|
N/A |
N/A |
1,037 |
281 |
Cash and Cash Equivalents at End of Period
|
N/A |
N/A |
$525 |
$1,037 |
|